Sigyn Therapeutics Inc. is a medical technology company. It is focused on the treatment of life-threatening inflammatory conditions. Sigyn Therapeutics Inc., formerly knonw as Reign Resources Corporation, is headquartered in San Diego, California USA.
| Revenue (Most Recent Fiscal Year) | -- |
| Net Income (Most Recent Fiscal Year) | $-3.34M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | -- |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -- |
| Return on Assets (Trailing 12 Months) | -2014.27% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.01 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.01 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | -- |
| Inventory Turnover (Trailing 12 Months) | 0.00 |
| Book Value per Share (Most Recent Fiscal Quarter) | $-3.08 |
| Earnings per Share (Most Recent Fiscal Quarter) | -- |
| Earnings per Share (Most Recent Fiscal Year) | -- |
| Diluted Earnings per Share (Trailing 12 Months) | $-4.57 |
| Exchange | -- |
| Sector | -- |
| Industry | -- |
| Common Shares Outstanding | 1.61M |
| Free Float | 0.35M |
| Market Capitalization | $4.00M |
| Average Volume (Last 20 Days) | 39.75 |
| Beta (Past 60 Months) | -1.03 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 78.46% |
| Percentage Held By Institutions (Latest 13F Reports) | 10.01% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |